ES541955A0 - Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas - Google Patents

Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas

Info

Publication number
ES541955A0
ES541955A0 ES541955A ES541955A ES541955A0 ES 541955 A0 ES541955 A0 ES 541955A0 ES 541955 A ES541955 A ES 541955A ES 541955 A ES541955 A ES 541955A ES 541955 A0 ES541955 A0 ES 541955A0
Authority
ES
Spain
Prior art keywords
vaccine
preparing
negative bacteria
against gram
immunization against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541955A
Other languages
English (en)
Other versions
ES8802117A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Missouri System
Original Assignee
University of Missouri System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Missouri System filed Critical University of Missouri System
Publication of ES541955A0 publication Critical patent/ES541955A0/es
Publication of ES8802117A1 publication Critical patent/ES8802117A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES541955A 1984-04-05 1985-04-03 Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas Expired ES8802117A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59711584A 1984-04-05 1984-04-05
US69700885A 1985-01-31 1985-01-31

Publications (2)

Publication Number Publication Date
ES541955A0 true ES541955A0 (es) 1988-04-01
ES8802117A1 ES8802117A1 (es) 1988-04-01

Family

ID=27082733

Family Applications (2)

Application Number Title Priority Date Filing Date
ES541955A Expired ES8802117A1 (es) 1984-04-05 1985-04-03 Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas
ES550947A Expired ES8802118A1 (es) 1984-04-05 1986-01-16 Un metodo para preparar un modulador inmune a base de un lipolisacarido bacteriano dextoxificado.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES550947A Expired ES8802118A1 (es) 1984-04-05 1986-01-16 Un metodo para preparar un modulador inmune a base de un lipolisacarido bacteriano dextoxificado.

Country Status (10)

Country Link
US (2) US5641492A (es)
EP (2) EP0540063A1 (es)
JP (3) JP2625099B2 (es)
AR (1) AR242903A1 (es)
AU (2) AU589552B2 (es)
CA (1) CA1263306A (es)
DE (1) DE3587681T2 (es)
ES (2) ES8802117A1 (es)
IE (1) IE940698L (es)
PH (1) PH23104A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
JPS62501726A (ja) * 1985-01-15 1987-07-09 ユニサ−チ リミテツド サルモネラ菌検出用イムノアツセイシステム
FI871174A (fi) * 1986-03-18 1987-09-19 Research Corp Foerfarande foer bestaemning av haptener med hjaelp av immunoanalysteknik.
EP0367757B1 (en) * 1986-05-23 1994-11-02 SANOFI ANIMAL HEALTH, Inc. Co-vaccination using non-o-carbohydrate side-chain gram-negative bacteria preparation
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US6887483B2 (en) * 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria
WO1998053851A1 (en) * 1997-05-28 1998-12-03 University Of Iowa Research Foundation Laft mutants of pathogenic gram-negative bacteria
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
EP1023903B1 (en) * 1999-01-26 2004-01-14 Akzo Nobel N.V. Use of life attenuated bacteria for the manufacture of a submucosal vaccine
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
US6379676B2 (en) * 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
WO2006130161A2 (en) * 2004-07-21 2006-12-07 The Cornell Research Foundation, Inc. Therapeutic compounds derived from spider venom and their method of use
EP2528620B1 (en) 2010-01-28 2019-06-05 Universiteit Gent Salmonella vaccine
WO2015192216A1 (en) 2014-06-20 2015-12-23 University Of Saskatchewan Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
CA3208643A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB164622A (en) * 1920-06-11 1921-06-16 C L I Mfg Company Ltd Improvements in lamp and other brackets for use on cycles and motor cycles
US3075883A (en) * 1961-11-08 1963-01-29 Cons Lab Inc Novel parenteral vaccine antigen compositions and methods of making and using
US4029762A (en) * 1971-11-17 1977-06-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Lipid A-preparation
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4148877A (en) * 1975-12-29 1979-04-10 Choay S. A. Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4567041A (en) * 1977-12-08 1986-01-28 Likhite Vilas V Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
US4530832A (en) * 1978-12-07 1985-07-23 Schering Corporation Method of vaccination for prevention of Bordetella bronchiseptica infection
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
US4327082A (en) * 1979-07-12 1982-04-27 Adcock-Ingram Laboratories Limited Mastitis vaccination
AU529322B2 (en) * 1979-07-27 1983-06-02 Pitman-Moore, Inc. Antigenic compositions
FR2464300B1 (fr) * 1979-08-29 1983-08-05 Agronomique Inst Nat Rech Preparation de souches salmonella abortus ovis et compositions de vaccins les contenant
US4491660A (en) * 1980-01-10 1985-01-01 Abbott Laboratories Matrix polymers for binding endotoxins
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US4328210A (en) * 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DE3022914A1 (de) * 1980-06-19 1981-12-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zurgewinnung eines anaphylatoxin und cocytotaxin enthaltenden leukotaxinpraeparates sowie von anaphylatoxin und cocytotaxin in molekular einheitlicher form
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4582790A (en) * 1983-02-15 1986-04-15 Wisconsin Alumni Research Foundation Monoclonal antibody to angiotension-converting enzyme and methods of preparing and using same
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
US4571336A (en) * 1983-08-25 1986-02-18 Endorphin, Inc. Immune stimulation
US4762712A (en) * 1983-08-31 1988-08-09 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4582798A (en) * 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation

Also Published As

Publication number Publication date
EP0158282A2 (en) 1985-10-16
AU634972B2 (en) 1993-03-11
JP2625099B2 (ja) 1997-06-25
JP2534032B2 (ja) 1996-09-11
JPH07250673A (ja) 1995-10-03
IE940698L (en) 1985-10-05
CA1263306A (en) 1989-11-28
AU4076785A (en) 1985-10-10
US5961985A (en) 1999-10-05
DE3587681T2 (de) 1994-07-07
JPH07252165A (ja) 1995-10-03
EP0158282A3 (en) 1988-05-25
PH23104A (en) 1989-04-10
ES550947A0 (es) 1988-04-01
AR242903A1 (es) 1993-06-30
EP0158282B1 (en) 1993-12-15
AU589552B2 (en) 1989-10-19
JP2638755B2 (ja) 1997-08-06
EP0540063A1 (en) 1993-05-05
ES8802117A1 (es) 1988-04-01
US5641492A (en) 1997-06-24
AU3910689A (en) 1989-11-23
DE3587681D1 (de) 1994-01-27
JPS6121A (ja) 1986-01-06
ES8802118A1 (es) 1988-04-01

Similar Documents

Publication Publication Date Title
ES541955A0 (es) Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas
AR231496A1 (es) Metodo para preparar una composicion de vacuna contra el virus herpes simplex
ES544638A0 (es) Un metodo para preparar un extracto capaz de inmunizar a los pollos contra la occidiosis.
ES515182A0 (es) Metodo para fijar una valvula de corazon.
ES524019A0 (es) Un metodo para producir una bebida en infusion
ES547049A0 (es) Un metodo para preparar una goma de mascar
ES545607A0 (es) Procedimiento para preparar una vacuna contra la coccidiosis
IT1147808B (it) Dispositivo per realizzare colture di microorganismi
AR228430A1 (es) Metodo para preparar una vacuna neumococcica multivalente de polisacaridos capsulares purificados
ES514617A0 (es) "un procedimiento para preparar una vacuna oral para inmunizacion contra enfermedades entericas".
ES540780A0 (es) Un procedimiento para preparar una solucion oftalmica
ES521411A0 (es) Un procedimiento para la preparacion de una vacuna contra picornavirus.
ES543093A0 (es) Un metodo para preparar una capsula blanda de etoposido
ES545606A0 (es) Procedimiento para preparar una vacuna contra la coccidiosis
MX158764A (es) Procedimiento mejorado para preparar una solucion oral contra la gingivitis
MX7115E (es) Procedimiento microbiologico para preparar acido 2,5-diceto-d-gluconico o una sal del mismo
ES505172A0 (es) Un metodo para preparar una composicion de gel acuoso semi- solido para alimentacion de heridos
MX7636E (es) Un metodo para la preparacion de una vacuna para la proteccion de aves de corral contra la bronquitis infecciosa
PT90311A (pt) Processo para a obtencao de proteinas antigenicas imunoprotectoras contra bacterias patogenicas
MX7384E (es) Un metodo para preparar una composicion germicida
AR221532A1 (es) Procedimiento para preparar una vacuna contra t.cruzi
ES523460A0 (es) Un metodo para preparar una composicion suavizante para tejidos
ES520809A0 (es) Un metodo para preparar una composicion suavizadora de tejidos.
AU1375683A (en) A method for cultivating water-living animals
ES508767A0 (es) Un metodo para preparar una vacuna contra vibrio anguillarum

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20151230